Program
Break
CME Session
EAS Stage
Foyer
Industry session
Joint Session
Late Breaker
Parallel session
Plenary
SaaG Session (Poster Screens)
Workshop
Break
CME Session
EAS Stage
Foyer
Industry session
Joint Session
Late Breaker
Parallel session
Plenary
SaaG Session (Poster Screens)
Workshop
| Time | Hall 1 | Exhibition | Foyer |
|---|---|---|---|
| 13:30-17:45 |
Industry Sponsored Session Program (Exact timings TBA)
|
||
| 14:45-15:00 |
Coffee Break
|
||
| 17:45-18:00 |
Break
|
||
| 18:00-19:15 |
Opening Ceremony incl. Anitschkow Lecture
|
||
| 19:15-21:00 |
Welcome Reception
|
| Time | Hall 1 | Hall 2 | Hall 3 | Hall 4 | Exhibition | EAS Stage in the Exhibition | Station 01 | Station 02 | Station 03 | Station 04 | Station 05 | Station 06 | Station 07 | Station 08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08:30-10:30 |
Plenary 1: Sex and gender in cardiovascular disease
|
|||||||||||||
| 10:30-11:00 |
Coffee break, Exhibition & Poster viewing
|
|||||||||||||
| 11:00-12:30 |
NLA/EAS joint session Early, Sustained, and Comprehensive Control of Lipids and Health: From Therapies to Models of Care
|
Workshop: Identifying Novel Therapeutic Approaches in Atherosclerosis
|
Workshop: (DE) Implementing new tools in clinical practice
|
Workshop: Atherosclerosis as a multi-organ disease
|
||||||||||
| 12:30-15:30 |
EAS Stage sessions
|
|||||||||||||
| 12:45-13:15 |
Keynote Lecture
|
|||||||||||||
| 13:30-15:30 |
Industry Sponsored Session - Not CME-accredited session
|
|||||||||||||
| 13:30-14:30 |
SaaG Session: The Endothelium as Gatekeeper in CVD
|
SaaG Session: Lipid Metabolism: Novel Regulators and Mechanisms
|
SaaG Session: Population Trends and Management Strategies in Cardiovascular Risk
|
SaaG Session: Advances in Vascular Therapeutics and Thrombosis Management
|
SaaG Session: FH and Inherited Dyslipidemias: Clinical Perspectives
|
SaaG Session: Diabetes: Cardiovascular Connections and Clinical Implications
|
SaaG Session: Emerging Lipid-Lowering Strategies: Mechanisms, Pre-clinical Studies and Outcomes
|
SaaG Session: AI and Advanced Analytics in Cardiovascular Research
|
||||||
| 14:35-15:35 |
SaaG Session: Arterial Wall Biology: From Molecular Mechanisms to Plaque Stability
|
SaaG Session: Inflammation in CVD: T Cells, Macrophages, and Beyond
|
SaaG Session: Lipoprotein Dynamics: HDL to Remnants
|
SaaG Session: Molecular Mechanisms and Biomarkers in Aortic Valve Stenosis
|
SaaG Session: Genetic insights in FH and Dyslipidemia
|
SaaG Session: Adipose Tissue: Molecular Insights and Cardiovascular Implications
|
SaaG Session: Next-Generation Lipid-Lowering: PCSK9 Inhibitors and Other Novel Targets
|
|||||||
| 15:30-15:45 |
Coffee Break
|
|||||||||||||
| 15:45-17:15 |
Workshop: New targets for therapy
|
Late breaker session 1
|
Workshop: Beyond conventional cardiovascular risk
|
ASPC/EAS Joint session - Triglycerides: From Pathophysiology to Clinical Practice
|
||||||||||
| 17:20-17:50 |
Debate session: Is LDL lowering a solved problem? TUE
|
|||||||||||||
| 17:20-18:50 |
Wine and science and poster viewing
|
| Time | Hall 1 | Hall 2 | Hall 3 | Hall 4 | Exhibition | EAS Stage in the Exhibition | Station 01 | Station 02 | Station 03 | Station 04 | Station 05 | Station 06 | Station 07 | Station 08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07:30-08:15 |
Industry Sponsored Session - Not CME-accredited session
|
|||||||||||||
| 08:30-10:30 |
Plenary 2: Non-traditional risk factors for atherosclerosis
|
|||||||||||||
| 10:30-11:00 |
Coffee break, Exhibition & Poster viewing
|
|||||||||||||
| 11:00-12:30 |
ESC/EAS joint symposium New Horizons in the Understanding of the Inflammatory Nature of Atherosclerosis
|
Workshop: e-Health, AI and big data
|
Workshop: HDL and other lipoproteins
|
Workshop: Young fellows session: The cardiovascular – brain axis
|
||||||||||
| 12:30-15:30 |
EAS Stage sessions
|
|||||||||||||
| 12:45-13:15 |
Hugh Sinclair lecture
|
|||||||||||||
| 13:30-15:30 |
Industry Sponsored Session - Not CME-accredited session
|
|||||||||||||
| 13:30-14:30 |
SaaG Session: The Multiple Faces of Smooth Muscle Cells
|
SaaG Session: Frontiers in Lipid Metabolism
|
SaaG Session: Novel Biomarkers and Molecular Mechanisms in CVD
|
SaaG Session: FH and Hypercholesterolemia: Emerging Therapies and Clinical Insights
|
SaaG Session: Immune Cell Dynamics in CVD: Monocytes, T Cells, Neutrophils, and Macrophages
|
SaaG Session: Neurological Disorders and Cardiovascular Interplay: Epigenetic and Metabolism
|
SaaG Session: Real-World Effectiveness in Lipid Management
|
SaaG Session: Emerging Therapies and Genetic Insights in Cardiovascular Risk Management
|
||||||
| 14:35-15:35 |
SaaG Session: Plaque Biology: Molecular Insights and Cellular Dynamics
|
SaaG Session: The importance of Lp(a)
|
SaaG Session: Cardiac Injury: Mechanisms and Detection
|
SaaG Session: Diabetes: Metabolic Signatures Unveiled
|
SaaG Session: Liver Pathophysiology: Metabolic Disorders and Cardiovascular Risk
|
SaaG Session: Integrative Approaches to Lipid Control and Cardiovascular Risk
|
SaaG Session: Epidemiology: From Prevention to Prognosis
|
|||||||
| 15:30-15:45 |
Coffee Break
|
|||||||||||||
| 15:45-17:15 |
Workshop: Lp(a) – Joint session with British Pharmacological Society
|
Workshop: Optimisation of clinical management with novel or established treatments
|
IAS/EAS Joint session: FH – Current status worldwide and how can implementation science help us improve
|
Workshop: Intercellular communication and atherosclerotic plaque phenotype
|
||||||||||
| 17:20-18:50 |
Wine and science and poster viewing
|
|||||||||||||
| 17:30-18:30 |
General Assembly
|
| Time | Hall 1 | Hall 2 | Hall 3 | Hall 4 | Exhibition |
|---|---|---|---|---|---|
| 07:30-08:15 |
Industry Sponsored Session - Not CME-accredited session
|
||||
| 08:30-10:30 |
Plenary 3: Artificial intellegence and atherosclerosis: A glimpse into the future
|
||||
| 10:30-11:00 |
Coffee break, Exhibition & Poster viewing
|
||||
| 11:00-12:30 |
Workshop: Inflammatory mechanisms in atherosclerosis
|
Workshop: Assessing the vulnerable patient using non-invasive imaging. Joint session with SCCT and BSCI/BSCCT
|
Late breaker session 2
|
Workshop: New risk factors for atherosclerotic disease Microparticals and microplastics in the vessels
|